Mesalazine (Systemic) vs Ustekinumab
National NHS prescribing compared (Prescription Cost Analysis)
Mesalazine (Systemic) was dispensed 130,186.0× as often as Ustekinumab in May 2026 — 130,186 items versus 1 in England.
130,186items
Mesalazine (Systemic) · May 2026
NHSBSA Prescription Cost Analysis
1items
Ustekinumab · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Mesalazine (Systemic) versus Ustekinumab: national items dispensed by month
▬ Mesalazine (Systemic) · ╌ Ustekinumab
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Mesalazine (Systemic) | Ustekinumab |
|---|---|---|
| Items, May 2026 | 130,186 | 1 |
| Items, last 12 months | 1,618,592 | 1 |
| Net ingredient cost, May 2026 | £7,516,097 | £2,147 |
See the full profile for Mesalazine (Systemic) or Ustekinumab.